News

25
Sep

Join us at the TechMeetings by University of Paris-Saclay

Meet with Genoskin at the TechMeetings on Interaction between skin/hair and cosmetics The Synchrotron SOLEIL facilities near Paris, France will welcome the 8th edition of the TechMeetings on October 3rd. Genoskin's Business Development Manager, Michael Pastore will participate in the event. The TechMeetings are organized by the University of Paris-Saclay and the Cosmetic Valley. The event will help create new partnerships
Read more
18
Sep

Genemarkers and Genoskin announce new partnership

Genemarkers, LLC and Genoskin, Inc. announce partnership to advance clinical studies of topical solutions September 18, 2019 - Kalamazoo, MI & Salem, MA Genemarkers and Genoskin are pleased to announce they have formed a partnership to provide exceptional value and service to researchers in the fields of cosmetic and pharmaceutical topical solutions. The Companies are currently performing collaborative work to
Read more
11
Sep

The EPA takes actionable steps to end animal testing

 The US Environmental Protection Agency (EPA) determined to eliminate animal testing The US Environmental Protection Agency announced yesterday its plan to stop animal use for chemical safety testing. The U.S. EPA rolled out a plan this week to end all animal testing for chemical and pesticide safety in the coming years. To help the transition, the agency will invest in nonanimal alternative methods
Read more
9
Sep

[ESDR2019] Genoskin continues collaboration with Promega

 [ESDR2019] New data on Genoskin's NativeSkin® in collaboration with Promega The 49th ESDR Annual Meeting is approaching. In less than two weeks, our team will be presenting our latest research in Bordeaux, France. To learn more about our latest work on NativeSkin®, come meet Dr. Michael Pastore, Genoskin Business Development Manager, on Thursday 19th at 5 pm, Friday 20th at 3:20
Read more
29
Aug

Genoskin awarded grant from Occitania

Genoskin awarded grant from Occitania The Occitania Region announced today that it awarded its coveted international development grant to Genoskin. The “Pass Export” grant is awarded to companies that demonstrate significant growth potential abroad. Pass-Export enables companies to pursue their development in new territories. “Genoskin is honored and grateful to be awarded this grant. As we continue to grow, we

Read more

27
Aug

[ESDR2019] Genoskin and Sanofi present Hypo-InflammaSkin®

 [ESDR2019] Genoskin partners with Sanofi to present Hypo-InflammaSkin® Genoskin’s team of skin experts will be presenting its latest work at the 49th ESDR Annual Meeting from September 18 to September 21 in Bordeaux, France. To discover our latest research and innovations, meet our Project Manager and Team leader Claire Jardet, Ph.D.  on Thursday 19th at 7 pm and Friday 20th at
Read more